P-109 Intestinal Transplantation for End Stage Crohn's Disease: Therapeutic Efficacy and Disease Recurrence
Koritsky D, Costa G, Bond G, Schuster B, Roberts M, Hoffman B, Stein W, Soltys K, Sogawa H, Rubin E, Regueiro M, Abu-Elmagd K. P-109 Intestinal Transplantation for End Stage Crohn's Disease: Therapeutic Efficacy and Disease Recurrence. Inflammatory Bowel Diseases 2012, 18: s58-s58. DOI: 10.1097/00054725-201212001-00142.Peer-Reviewed Original ResearchIrreversible intestinal failureDisease recurrenceCrohn's diseaseRecipient pretreatmentSurvival rateChronic rejectionGraft lossIntestinal failureMultivisceral transplantationTPN therapyGraft functionSurvival outcomesIntestinal transplantationTherapeutic efficacyActuarial patient survival ratesRisk of graft lossLongterm survival outcomesPositive lymphocytotoxic crossmatchDisease patientsConsecutive adult patientsYear survival rateTime of transplantationNon-Crohn's disease patientsPatient survival ratesLong-term outcomesO-4 Intestinal Transplantation for End Stage Crohn's Disease: Therapeutic Efficacy and Disease Recurrence
Koritsky D, Costa G, Bond G, Schuster B, Roberts M, Hoffman B, Stein W, Soltys K, Sogawa H, Rubin E, Regueiro M, Abu-Elmagd K. O-4 Intestinal Transplantation for End Stage Crohn's Disease: Therapeutic Efficacy and Disease Recurrence. Inflammatory Bowel Diseases 2012, 18: s3-s3. DOI: 10.1097/00054725-201212001-00005.Peer-Reviewed Original ResearchIrreversible intestinal failureDisease recurrenceCrohn's diseaseRecipient pretreatmentSurvival rateChronic rejectionGraft lossIntestinal failureMultivisceral transplantationTPN therapySurvival outcomesGraft functionIntestinal transplantationTherapeutic efficacyActuarial patient survival ratesLong-term survival outcomesRisk of graft lossPositive lymphocytotoxic crossmatchDisease patientsConsecutive adult patientsYear survival rateTime of transplantationNon-Crohn's disease patientsPatient survival ratesLong-term outcomes
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply